サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1326531

鉄剤静注の世界市場規模調査＆予測、製品別、用途別、地域別分析、2023-2030年

Global Intravenous Iron Drugs Market Size study & Forecast, by Product (Iron Sucrose, Iron Dextran, Ferric Carboxymaltose, Others), by Application (Chronic Kidney Disease, Inflammatory Bowel Disease, Cancer, Others) and Regional Analysis, 2023-2030

出版日
ページ情報
英文
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
鉄剤静注の世界市場規模調査＆予測、製品別、用途別、地域別分析、2023-2030年
出版日: 2023年07月28日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

鉄剤静注の世界市場規模は2022年に約29億2,000万米ドルで、予測期間2023-2030年には8.6%以上の健全な成長率で成長すると予測されています。

鉄剤静注は、体内の鉄貯蔵量を補充するために血流に直接投与される薬剤です。経口鉄サプリメントが有効でない、あるいは適さない場合に使用されます。これらの薬剤は、体内の鉄レベルを急速に上昇させることにより、鉄欠乏性貧血の治療に役立ちます。慢性腎臓病、炎症性腸疾患、がんの有病率の上昇は、鉄剤静注の重要な適応症であり、市場成長の重要な促進要因です。さらに、マラリア、HIV/AIDS、結核、肝炎、肺炎、インフルエンザなどの感染症の罹患率の増加は、静脈注射薬の需要を将来的に増加させると予想されます。

さらに、がんの有病率の増加は、鉄剤静注市場の成長をサポートすることができます。2022年のWHOによると、がんは2020年に約1,000万人の死亡の原因となっており、依然として世界的に顕著な死亡原因となっています。2020年におけるがんの新規患者数では、乳がんが226万人、次いで肺がんが221万人、結腸・直腸がんが193万人、前立腺がんが141万人、非黒色腫皮膚がんが120万人、胃がんが109万人となっています。また、医薬品開発への投資が増加しており、予測期間中に市場にとって有利な機会が生まれると予想されます。しかし、鉄剤静注に伴う副作用が、2023-2030年の予測期間を通じて市場の成長を阻害しています。

鉄剤静注の世界市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカです。北米は、慢性腎臓病、消化器疾患、がんの有病率の増加により、2022年の市場を独占しました。アジア太平洋地域は、政府の支援策とヘルスケアインフラの整備により、予測期間中に最も速い成長率で成長すると予想されます。また、中国やインドなどの新興国では慢性腎臓病の罹患率が高く、市場の成長を後押ししています。

本調査の目的は、近年におけるさまざまなセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的・量的側面の両方を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

第2章 世界の鉄剤静注市場の定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 業界の進化
    • 調査範囲
  • 調査対象年
  • 通貨換算レート

第3章 鉄剤静注の世界市場力学

  • 鉄剤静注市場の影響分析（2020年～2030年）
    • 市場促進要因
      • 慢性腎臓病の増加
      • 感染症の増加
    • 市場の課題
      • 鉄剤静注に伴う副作用
    • 市場機会
      • 医薬品開発への投資拡大

第4章 世界の鉄剤静注市場産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォース影響分析
  • PEST分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 主な投資機会
  • 主要成功戦略
  • COVID-19影響分析
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの結論・提言

第5章 鉄剤静注の世界市場：製品別

  • 市場スナップショット
  • 鉄剤静注の世界市場：製品別、実績 - ポテンシャル分析
  • 鉄剤静注の世界市場：製品別、推定・予測2020～2030年
  • 鉄剤静注市場、サブセグメント別分析
    • スクロース鉄
    • デキストラン鉄
    • カルボキシマルトース鉄
    • その他

第6章 鉄剤静注の世界市場：用途別

  • 市場スナップショット
  • 鉄剤静注の世界市場：用途別、実績 - ポテンシャル分析
  • 鉄剤静注の世界市場：用途別、推定・予測2020～2030年
  • 鉄剤静注市場、サブセグメント分析
    • 慢性腎臓病
    • 炎症性腸疾患
    • がん
    • その他

第7章 鉄剤静注の世界市場、地域分析

  • 主要国
  • 主な新興国
  • 鉄剤静注市場、地域別市場スナップショット
  • 北米
    • 米国
      • 製品の推定・予測、2020-2030年
      • 用途別推定・予測、2020-2030年
    • カナダ
  • 欧州の鉄剤静注市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋の鉄剤静注市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカの鉄剤静注市場スナップショット
    • ブラジル
    • メキシコ
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • その他中東とアフリカ

第8章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • CSL Limited
      • 主要情報
      • 概要
      • 財務（データの入手可能性によります）
      • 製品概要
      • 最近の動向
    • Covis Pharma GmbH
    • Daiichi Sankyo Company, Ltd.
    • Sanofi S.A.
    • Pharma cosmos A/S
    • Shield Therapeutics Plc
    • AbbVie Inc.
    • Rockwell Medical Inc
    • Americal Reagent Inc
    • Pfizer Inc.

第9章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査属性
  • 調査前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Intravenous Iron Drugs Market, report scope
  • TABLE 2. Global Intravenous Iron Drugs Market estimates & forecasts by Region 2020-2030 (USD Billion)
  • TABLE 3. Global Intravenous Iron Drugs Market estimates & forecasts by Product 2020-2030 (USD Billion)
  • TABLE 4. Global Intravenous Iron Drugs Market estimates & forecasts by Application 2020-2030 (USD Billion)
  • TABLE 5. Global Intravenous Iron Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 6. Global Intravenous Iron Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 7. Global Intravenous Iron Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 8. Global Intravenous Iron Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9. Global Intravenous Iron Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10. Global Intravenous Iron Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11. Global Intravenous Iron Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12. Global Intravenous Iron Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13. Global Intravenous Iron Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14. Global Intravenous Iron Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15. U.S. Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16. U.S. Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 17. U.S. Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 18. Canada Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 19. Canada Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 20. Canada Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 21. UK Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 22. UK Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 23. UK Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 24. Germany Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 25. Germany Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 26. Germany Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 27. France Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 28. France Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 29. France Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 30. Italy Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 31. Italy Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 32. Italy Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 33. Spain Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 34. Spain Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 35. Spain Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 36. RoE Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 37. RoE Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 38. RoE Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 39. China Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 40. China Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 41. China Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 42. India Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 43. India Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 44. India Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 45. Japan Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 46. Japan Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 47. Japan Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 48. South Korea Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 49. South Korea Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 50. South Korea Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 51. Australia Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 52. Australia Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 53. Australia Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 54. RoAPAC Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 55. RoAPAC Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 56. RoAPAC Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 57. Brazil Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 58. Brazil Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 59. Brazil Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 60. Mexico Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 61. Mexico Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 62. Mexico Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 63. RoLA Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 64. RoLA Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 65. RoLA Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 66. Saudi Arabia Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 67. South Africa Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 68. RoMEA Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 69. List of secondary sources, used in the study of global Intravenous Iron Drugs Market
  • TABLE 70. List of primary sources, used in the study of global Intravenous Iron Drugs Market
  • TABLE 71. Years considered for the study
  • TABLE 72. Exchange rates considered

List of tables and figures are dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

  • FIG 1. Global Intravenous Iron Drugs Market, research methodology
  • FIG 2. Global Intravenous Iron Drugs Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Intravenous Iron Drugs Market, key trends 2022
  • FIG 5. Global Intravenous Iron Drugs Market, growth prospects 2023-2030
  • FIG 6. Global Intravenous Iron Drugs Market, porters 5 force model
  • FIG 7. Global Intravenous Iron Drugs Market, pest analysis
  • FIG 8. Global Intravenous Iron Drugs Market, value chain analysis
  • FIG 9. Global Intravenous Iron Drugs Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10. Global Intravenous Iron Drugs Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11. Global Intravenous Iron Drugs Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12. Global Intravenous Iron Drugs Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13. Global Intravenous Iron Drugs Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14. Global Intravenous Iron Drugs Market, regional snapshot 2020 & 2030
  • FIG 15. North America Intravenous Iron Drugs Market 2020 & 2030 (USD Billion)
  • FIG 16. Europe Intravenous Iron Drugs Market 2020 & 2030 (USD Billion)
  • FIG 17. Asia pacific Intravenous Iron Drugs Market 2020 & 2030 (USD Billion)
  • FIG 18. Latin America Intravenous Iron Drugs Market 2020 & 2030 (USD Billion)
  • FIG 19. Middle East & Africa Intravenous Iron Drugs Market 2020 & 2030 (USD Billion)

List of tables and figures are dummy in nature, final lists may vary in the final deliverable

目次

Global Intravenous Iron Drugs Market is valued at approximately USD 2.92 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 8.6% over the forecast period 2023-2030. Intravenous iron drugs are medications administered directly into the bloodstream to replenish iron stores in the body. They are used when oral iron supplements are ineffective or not suitable. These drugs help treat iron deficiency anemia by rapidly increasing iron levels in the body. The rising prevalence of chronic kidney disease, inflammatory bowel disease, and cancer, which are important indications for intravenous iron usage, is a significant driver for market growth. Additionally, the growing incidence of infectious diseases such as malaria, HIV/AIDS, TB, hepatitis, pneumonia, and influenza is expected to increase the demand for intravenous drugs in the future.

Moreover, the growing prevalence of cancer can support the growth of the Intravenous Iron Drugs Market. According to the WHO in 2022, Cancer, responsible for nearly 10 million deaths in 2020, remains a prominent global cause of mortality. In terms of new cases of cancer in 2020, the following were the most prevalent: Breast cancer accounted for 2.26 million cases, followed by lung cancer with 2.21 million cases, colon and rectum cancer with 1.93 million cases, prostate cancer with 1.41 million cases, non-melanoma skin cancer with 1.20 million cases, and stomach cancer with 1.09 million cases in 2020. Additionally, an growing investment in drugs development is anticipated to create the lucrative opportunity for the market during forecast period. However, adverse reactions associated with intravenous iron drugs stifling market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Intravenous Iron Drugs Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the increasing prevalence of chronic kidney disease, gastrointestinal illnesses, and cancers in the region. Asia Pacific is expected to grow at fastest growth rate during the forecast period, owing to supportive government initiatives and the development of healthcare infrastructure. In addition, the high incidence of chronic kidney disease in developing nations such as China and India have aided market growth.

Major market player included in this report are:

  • CSL Limited
  • Covis Pharma GmbH
  • Daiichi Sankyo Company, Ltd.
  • Sanofi S.A.
  • Pharma cosmos A/S
  • Shield Therapeutics Plc
  • AbbVie Inc.
  • Rockwell Medical Inc
  • Americal Reagent Inc
  • Pfizer Inc.

Recent Developments in the Market:

  • In November 2022, Fer inject an intravenous iron therapy, obtained approval from China's National Medical Products Administration (NMPA). This approval allows CSL Vifor and Fresenius Kabi to utilize Fer inject for treating iron deficiency in adult patients who are unresponsive to oral iron preparations, unable to use them, or require rapid iron delivery due to clinical necessity.
  • In November 2022, a group of researchers funded by the National Institutes of Health (NIH) initiated a study to investigate the effectiveness of intravenous iron drug treatment for women with post-pregnancy anemia. The study aims to enrol approximately 5,000 women across multiple countries, including India, Bangladesh, Pakistan, the Democratic Republic of Congo, Kenya, Zambia, and Guatemala.

Global Intravenous Iron Drugs Market Report Scope:

  • Historical Data: 2020 - 2021
  • Base Year for Estimation: 2022
  • Forecast period: 2023-2030
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Product, Application, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

  • Iron Sucrose
  • Iron Dextran
  • Ferric Carboxymaltose
  • Others

By Application:

  • Chronic Kidney Disease
  • Inflammatory Bowel Disease
  • Cancer
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Intravenous Iron Drugs Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2. Intravenous Iron Drugs Market, by Product, 2020-2030 (USD Billion)
    • 1.2.3. Intravenous Iron Drugs Market, by Application, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Intravenous Iron Drugs Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Intravenous Iron Drugs Market Dynamics

  • 3.1. Intravenous Iron Drugs Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Rising Incidences of Chronic Kidney Disease
      • 3.1.1.2. Growing incidence of infectious diseases
    • 3.1.2. Market Challenges
      • 3.1.2.1. Adverse reactions associated with intravenous iron drugs
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Growing investment in drugs development

Chapter 4. Global Intravenous Iron Drugs Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Intravenous Iron Drugs Market, by Product

  • 5.1. Market Snapshot
  • 5.2. Global Intravenous Iron Drugs Market by Product, Performance - Potential Analysis
  • 5.3. Global Intravenous Iron Drugs Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
  • 5.4. Intravenous Iron Drugs Market, Sub Segment Analysis
    • 5.4.1. Iron Sucrose
    • 5.4.2. Iron Dextran
    • 5.4.3. Ferric Carboxymaltose
    • 5.4.4. Others

Chapter 6. Global Intravenous Iron Drugs Market, by Application

  • 6.1. Market Snapshot
  • 6.2. Global Intravenous Iron Drugs Market by Application, Performance - Potential Analysis
  • 6.3. Global Intravenous Iron Drugs Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
  • 6.4. Intravenous Iron Drugs Market, Sub Segment Analysis
    • 6.4.1. Chronic Kidney Disease
    • 6.4.2. Inflammatory Bowel Disease
    • 6.4.3. Cancer
    • 6.4.4. Others

Chapter 7. Global Intravenous Iron Drugs Market, Regional Analysis

  • 7.1. Top Leading Countries
  • 7.2. Top Emerging Countries
  • 7.3. Intravenous Iron Drugs Market, Regional Market Snapshot
  • 7.4. North America Intravenous Iron Drugs Market
    • 7.4.1. U.S. Intravenous Iron Drugs Market
      • 7.4.1.1. Product breakdown estimates & forecasts, 2020-2030
      • 7.4.1.2. Application breakdown estimates & forecasts, 2020-2030
    • 7.4.2. Canada Intravenous Iron Drugs Market
  • 7.5. Europe Intravenous Iron Drugs Market Snapshot
    • 7.5.1. U.K. Intravenous Iron Drugs Market
    • 7.5.2. Germany Intravenous Iron Drugs Market
    • 7.5.3. France Intravenous Iron Drugs Market
    • 7.5.4. Spain Intravenous Iron Drugs Market
    • 7.5.5. Italy Intravenous Iron Drugs Market
    • 7.5.6. Rest of Europe Intravenous Iron Drugs Market
  • 7.6. Asia-Pacific Intravenous Iron Drugs Market Snapshot
    • 7.6.1. China Intravenous Iron Drugs Market
    • 7.6.2. India Intravenous Iron Drugs Market
    • 7.6.3. Japan Intravenous Iron Drugs Market
    • 7.6.4. Australia Intravenous Iron Drugs Market
    • 7.6.5. South Korea Intravenous Iron Drugs Market
    • 7.6.6. Rest of Asia Pacific Intravenous Iron Drugs Market
  • 7.7. Latin America Intravenous Iron Drugs Market Snapshot
    • 7.7.1. Brazil Intravenous Iron Drugs Market
    • 7.7.2. Mexico Intravenous Iron Drugs Market
  • 7.8. Middle East & Africa Intravenous Iron Drugs Market
    • 7.8.1. Saudi Arabia Intravenous Iron Drugs Market
    • 7.8.2. South Africa Intravenous Iron Drugs Market
    • 7.8.3. Rest of Middle East & Africa Intravenous Iron Drugs Market

Chapter 8. Competitive Intelligence

  • 8.1. Key Company SWOT Analysis
    • 8.1.1. Company 1
    • 8.1.2. Company 2
    • 8.1.3. Company 3
  • 8.2. Top Market Strategies
  • 8.3. Company Profiles
    • 8.3.1. CSL Limited
      • 8.3.1.1. Key Information
      • 8.3.1.2. Overview
      • 8.3.1.3. Financial (Subject to Data Availability)
      • 8.3.1.4. Product Summary
      • 8.3.1.5. Recent Developments
    • 8.3.2. Covis Pharma GmbH
    • 8.3.3. Daiichi Sankyo Company, Ltd.
    • 8.3.4. Sanofi S.A.
    • 8.3.5. Pharma cosmos A/S
    • 8.3.6. Shield Therapeutics Plc
    • 8.3.7. AbbVie Inc.
    • 8.3.8. Rockwell Medical Inc
    • 8.3.9. Americal Reagent Inc
    • 8.3.10. Pfizer Inc.

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
  • 9.3. Research Assumption